Evidence map›Paper›PMID 25176415›Full record

ArticleBMC research notes2014

Severe phenotype in an apparent homozygosity caused by a large deletion in the CFTR gene: a case report.

Raisa da Silva Martins, Ana Carolina Proença Fonseca, Franklyn Enrique Samudio Acosta, Tania Wrobel Folescu, Laurinda Yoko Shinzato Higa, Izabela Rocha Sad, Célia Regina Moutinho de Miranda Chaves, Pedro Hernan Cabello, Giselda Maria Kalil Cabello

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC research notes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Identification and Characterization of NewFrontiers in genetics · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Raisa da Silva Martins
Ana Carolina Proença Fonseca
Franklyn Enrique Samudio Acosta
Tania Wrobel Folescu
Laurinda Yoko Shinzato Higa
Izabela Rocha Sad
Célia Regina Moutinho de Miranda Chaves
Pedro Hernan Cabello
Giselda Maria Kalil CabelloLaboratório de Genética Humana, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Pavilhão Leônidas Deane sala 611, CEP: 21040-360 Avenida Brasil 4365, Rio de Janeiro, Brazil. gkalil.fiocruz@gmail.com.
Instituto Nacional de Saúde · MZFundação Oswaldo Cruz · BRInstituto Conmemorativo Gorgas de Estudios de la Salud · PA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver 1900 mutations have been identified in the cystic fibrosis conductance transmembrane regulator gene, including single nucleotide substitutions, insertions, and deletions. Unidentified mutations may still lie in introns or in regulatory regions, which are not routinely investigated, or in large genomic deletions, which are not revealed by conventional molecular analysis. The apparent homozygosity for a rare, cystic fibrosis conductance transmembrane regulator mutation screened by standard molecular analysis should be further investigated to confirm if the mutation is in fact homozygous. We describe a patient presenting with an apparent homozygous S4X mutation. CASE PRESENTATION: A 13-year-old female patient of African descent with clinical symptoms of classic cystic fibrosis and a positive sweat test (97 mEq/L, diagnosed at age 3 years) presented with pancreatic insufficiency and severe pulmonary symptoms (initial lung colonization with Pseudomonas aeruginosa at age 4 years; forced vital capacity: 69%; forced expiratory volume: 51%; 2011). Furthermore, she developed severe acute lung disease and recurrent episodes of dehydration requiring hospitalization. The girl carried the CFTR mutation S4X in apparent homozygosity. However, further analysis revealed a large deletion in the second allele that included the region of the mutation. The deletion that we describe includes nucleotides 120-142, which correspond to a loss of 23 nucleotides that abolishes the normal translation initiation codon.

conclusionThis study reiterates the view that large, cystic fibrosis conductance transmembrane regulator deletions are an important cause of severe cystic fibrosis and emphasizes the importance of including large deletions/duplications in cystic fibrosis conductance transmembrane regulator diagnostic tests.

Indexed as

Gene DeletionHomozygotePhenotypeAdolescentCystic Fibrosis Transmembrane Conductance RegulatorFemaleHumansCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID25176415
PMCPMC4158034
OpenAlexW1995003624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.